Chronic inhibitory effect of follicle-stimulating hormone (FSH)-suppressing protein (FSP) or follistatin on activin- and gonadotropin-releasing hormone-stimulated FSH synthesis and secretion in cultured rat anterior pituitary cells
- PMID: 2117527
- DOI: 10.1210/endo-127-3-1385
Chronic inhibitory effect of follicle-stimulating hormone (FSH)-suppressing protein (FSP) or follistatin on activin- and gonadotropin-releasing hormone-stimulated FSH synthesis and secretion in cultured rat anterior pituitary cells
Abstract
The effects of bovine FSH-suppressing protein (FSP) or follistatin on activin- and GnRH-stimulated FSH synthesis and secretion have been studied using cultured pituitary cells from adult male Sprague-Dawley rats. Exposure to FSP (0.001-10 nM) for 3 days dose-dependently suppressed basal FSH secretion (IC50 = 146 +/- 21 pM., mean +/- SE), cellular content (IC50 = 269 +/- 8 pM) and total FSH (IC50 = 181 +/- 25 pM), with no effect on LH. Activin (0.3 nM) increased FSH secretion 2.1-fold, cellular content 1.3-fold, and total FSH 1.9-fold during a 3-day incubation, but these increases were dose-dependently inhibited by concomitant treatment with 35-kDa bovine FSP (0.1-3 nM), with complete inhibition occurring at concentrations between 1 and 3 nM. The 31- and 39-kDa forms of bovine FSP also antagonized the actions of activin. GnRH (1 nM) increased FSH secretion 1.8-fold and total FSH 1.6-fold during a 3-day incubation, effects that were dose-dependently inhibited by concomitant treatment with 35-kDa bovine FSP. The highest tested concentration of FSP (3 nM) suppressed GnRH-stimulated FSH secretion and total FSH to 59 and 57%, respectively, of the levels found in untreated cultures. All three forms of bovine FSP produced a significant inhibition of FSH secretion and total FSH stimulated by GnRH. FSP also suppressed FSH secretion and total FSH in response to activators of protein kinase C including 100 nM phorbol 12-myristate 13-acetate (43 and 59%, respectively) and 100 nM mezerein (40 and 60%, respectively). Finally, treatment of cultured pituitary cells with 35-kDa FSP at 1 and 3 nM for 3 days resulted in 21 and 24% decreases in GnRH binding sites, respectively. It is concluded that (i) FSP inhibits not only the secretion but also the synthesis of FSH induced by activin and GnRH in long-term culture, and (ii) FSP may cause its inhibitory effects on GnRH by suppression of the protein kinase C system, and possibly by reduction of GnRH binding sites.
Similar articles
-
Acute inhibitory effect of follicle-stimulating hormone-suppressing protein (FSP) on gonadotropin-releasing hormone-stimulated gonadotropin secretion in cultured rat anterior pituitary cells.Mol Cell Endocrinol. 1990 Jul 30;72(1):33-42. doi: 10.1016/0303-7207(90)90237-3. Mol Cell Endocrinol. 1990. PMID: 2125565
-
Effect of inhibin on activators of protein kinase-C and calcium-mobilizing agents which stimulate secretion of gonadotropins in vitro: implication of a postgonadotropin-releasing hormone receptor effect of inhibin on gonadotropin release.Endocrinology. 1990 Jun;126(6):3210-7. doi: 10.1210/endo-126-6-3210. Endocrinology. 1990. PMID: 2161751
-
Effects of bovine 35 kDa FSH-suppressing protein on FSH and LH in rat pituitary cells in vitro: comparison with bovine 31 kDa inhibin.J Endocrinol. 1990 Mar;124(3):417-23. doi: 10.1677/joe.0.1240417. J Endocrinol. 1990. PMID: 2110239
-
Pituitary effects of steroid hormones on secretion of follicle-stimulating hormone and luteinizing hormone.Domest Anim Endocrinol. 2002 Jul;23(1-2):33-42. doi: 10.1016/s0739-7240(02)00143-1. Domest Anim Endocrinol. 2002. PMID: 12142224 Review.
-
Inhibins, activins, and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone.Endocr Rev. 1988 May;9(2):267-93. doi: 10.1210/edrv-9-2-267. Endocr Rev. 1988. PMID: 3136011 Review.
Cited by
-
Regulation of follistatin messenger ribonucleic acid levels in the rat pituitary.J Clin Invest. 1993 Jun;91(6):2523-31. doi: 10.1172/JCI116488. J Clin Invest. 1993. PMID: 8514864 Free PMC article.
-
Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease.Muscle Nerve. 2009 Mar;39(3):283-96. doi: 10.1002/mus.21244. Muscle Nerve. 2009. PMID: 19208403 Free PMC article. Review.
-
Cloning and analysis of the mouse follistatin promoter.Mol Biol Rep. 2000 Sep;27(3):129-39. doi: 10.1023/a:1007159031000. Mol Biol Rep. 2000. PMID: 11254102
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources